Transparency in reporting of phase 3 cancer clinical trial results.
Acta Oncol
; 60(2): 191-194, 2021 Feb.
Article
in En
| MEDLINE
| ID: mdl-33307924
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Research Design
/
Neoplasms
Limits:
Humans
Language:
En
Journal:
Acta Oncol
Journal subject:
NEOPLASIAS
Year:
2021
Type:
Article
Affiliation country:
United States